Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kanglihua Consulting Services (KCL) is a leading Chinese regulatory affairs and GXP compliance consulting firm serving the pharmaceutical, biotechnology, and medical device industries. Founded in 1998, the company provides a comprehensive suite of services including NMPA, FDA, and EMA registration, GMP/GXP auditing, and clinical trial management. KCL assists both domestic Chinese companies seeking international expansion and multinational firms entering the Chinese market. Their expertise spans across small molecules, biologics, and medical devices, ensuring compliance with global quality standards. The firm is recognized for its deep understanding of the evolving regulatory landscape in China and its ability to facilitate international market access. KCL operates as a strategic partner for life science companies throughout the product development and commercialization lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kanglihua Consulting Services.